Consolidated Balance Sheets (USD $) In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Current assets:
Cash and cash equivalents	$ 75	$ 267
Accounts receivable	214	295
Prepaid expenses and other current assets	32	107
Total current assets	321	669
Property and equipment, net	0	5
Goodwill	0	3,418
Patents and other intangible assets, net	947	1,213
Other long-term assets	16	0
Total assets	1,284	5,305
Current liabilities:
Accounts payable	463	236
Accrued expenses	303	291
Deferred revenues and customer prepayments	1,151	2,252
Note payable	242	56
Derivative financial instruments - warrants	2	620
Derivative financial instruments - Series C and D preferred stock and debentures payable	6	296
Debentures payable - carried at fair value	37,384	38,250
Total current liabilities	39,551	42,001
Commitments and contingencies (Notes 2, 4, 8)
Shareholders' deficit:
Preferred stock	4,680	5,164
Common stock, no par value, 7,500,000,000 shares authorized, 4,166,142,620 and 332,321,818 shares issued and outstanding as of December 31, 2014 and 2013, respectively	4,985	4,985
Additional paid-in capital	192,224	190,946
Accumulated deficit	(239,377)	(236,910)
Accumulated other comprehensive loss	0	(102)
Treasury stock, at cost, 2,012 shares of common stock	(779)	(779)
Total shareholders' deficit	(42,947)	(41,860)
Total liabilities and shareholders' deficit	1,284	5,305
Series C Convertible Preferred Stock [Member]
Shareholders' deficit:
Preferred stock	4,332	4,816
Series D Convertible Preferred Stock [Member]
Shareholders' deficit:
Preferred stock	$ 348	$ 348